The first Myriad Genetics trade was made in Q4 2017.
Since then Jeremy Grantham bought shares two more times and sold shares on three occasions. The investor sold all their shares in Q4 2019 and doesn't own any shares in Myriad Genetics anymore.
Avg closing price
Price range
Sold -34 Thousand shares
Q4 2019
Avg closing price
$27.51
Price range
$20.93
-
$35.10
New holding (+34 Thousand shares)
Q3 2019
Avg closing price
$29.14
Price range
$22.08
-
$47.08
Sold -15.2 Thousand shares
Q1 2019
Avg closing price
$30.44
Price range
$26.93
-
$34.70
Sold 20.4% shares (-3.9 Thousand shares)
Q3 2018
Avg closing price
$44.47
Price range
$37.57
-
$50.34
Increased shares by 36.4% (+5.1 Thousand shares)
Q1 2018